Goh H S, Chan C S, Khine K, Smith D R
Department of Colorectal Surgery, Singapore General Hospital.
Lancet. 1994 Jul 23;344(8917):233-4. doi: 10.1016/s0140-6736(94)93000-7.
The tumour suppressor gene p53 is altered in most colorectal tumours. We found that lymphatic dissemination was driven by the presence of mutated p53 whether or not the cell contained wild-type p53. In a total sample of 187 specimens, point mutation of the p53 gene occurred in 70% and 43% of cases with and without lymph-node involvement, respectively. By contrast, haematogenous dissemination was apparently the result of absent functional wild-type p53 (whether or not the cell contained mutated p53). These results are of potential importance in the prediction of the clinical behaviour of a tumour.
大多数结直肠癌肿瘤中肿瘤抑制基因p53会发生改变。我们发现,无论细胞是否含有野生型p53,淋巴转移均由突变型p53的存在所驱动。在总共187个标本的样本中,p53基因的点突变分别发生在70%有淋巴结受累和43%无淋巴结受累的病例中。相比之下,血行转移显然是功能性野生型p53缺失的结果(无论细胞是否含有突变型p53)。这些结果在预测肿瘤的临床行为方面具有潜在的重要意义。